Hetero Ring Is One Of The Cyclos Of The Polycyclo Ring System Patents (Class 540/16)
  • Patent number: 10283719
    Abstract: An object of the present invention is to provide a compound which, when used for organic semiconductor films in organic thin-film transistors, makes the organic thin-film transistors exhibit a high carrier mobility, a material for an organic thin-film transistor for which the compound is used, a composition for an organic thin-film transistor, an organic thin-film transistor and a method for manufacturing the same, and an organic semiconductor film. An organic thin-film transistor of the present invention contains a compound represented by General Formula (1) in an organic semiconductor film (organic semiconductor layer) thereof.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: May 7, 2019
    Assignees: FUJIFILM Corporation, THE UNIVERSITY OF TOKYO
    Inventors: Masashi Koyanagi, Hiroaki Tsuyama, Eiji Fukuzaki, Yoshihisa Usami, Tetsuya Watanabe, Takashi Goto, Toshihiro Okamoto, Junichi Takeya
  • Publication number: 20150140088
    Abstract: The present invention relates to the fields of chemistry and pharmacy and, in particular, to the production of novel molecular entities: esterane derivatives fused with spirostanes rings, acting upon the Central Nervous Systems (CNS). From diosgenin, a naturally occurring sapogenin, with some subsequent transformations thereof, spirosteroid derivatives of the I-IV general formula can be obtained, with a cyclopentaneperhydrophenantrene nucleus fused to a 25R-spirostanes nucleus. Such molecular entities have an anti-inflammatory and anti-glutamatergic actions that can be used to treat inflammatory, cerebrovascular, neurodegenerative, neuropsychiatric, and neurologic diseases.
    Type: Application
    Filed: December 27, 2012
    Publication date: May 21, 2015
    Inventors: Laura Garcia Pupo, Yanier Nuñez Figueredo, Juan Enrique Tacoronte Morales, Yamila Verdecia Reyes, Estael Ochoa Rodriguez, Zaldo Castro Armando
  • Publication number: 20120258923
    Abstract: A series cardenolide derivatives including structure of formula I from the root of Reevesia formosana have provided. In formula (1) and (2), where R3, R5, R10 and R16 are as defined in the specification. The derivatives compounds showed potent cytotoxicity against MCF-7, NCI-H460, and HepG2 cancer cell lines.
    Type: Application
    Filed: October 4, 2011
    Publication date: October 11, 2012
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Ih-Sheng Chen, Hsun-Shuo Chang
  • Publication number: 20120077777
    Abstract: The present invention relates to a compound of following formula (I): or to a pharmaceutically acceptable salt thereof, as well as to pharmaceutical compositions including same and to the use thereof as a drug, in particular for treating a proliferative disease such as cancer.
    Type: Application
    Filed: May 20, 2010
    Publication date: March 29, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), PIERRE FABRE MEDICAMENT
    Inventors: Christophe Long, Yves Guminski, Fadila Derguini, Joséphine Beck, Frédéric Cantagrel
  • Publication number: 20080194812
    Abstract: The invention relates to a process for the preparation of 17-hydroxy-6?,7?;15?,16?-bismethylene-17?-pregn-4-ene-3-one-21-carboxylic acid ?-lactone of formula (I) as well as to key-intermediates for this process.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 14, 2008
    Inventors: Gyorgy Galik, Judit Horvath, Bela Soros, Sandor Maho, Zoltan Tuba, Gabor Balogh
  • Patent number: 7331997
    Abstract: Compositions for the oxidative dyeing of keratin fibers, comprising a medium suitable for dyeing and one or more tricyclic fused 6-5-6 heteroaromatic keratin dyeing compounds having one heteroatom. A method for oxidative dyeing of keratin fibers, comprising applying such compositions in the presence of an oxidizing agent, for a period sufficient to develop the desired coloration.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: February 19, 2008
    Assignee: The Procter & Gamble Company
    Inventors: Robert Wayne Glenn, Jr., Anthony McMeekin, Mu'Ill Lim, John Michael Gardlik, Stevan David Jones, Bryan Patrick Murphy
  • Patent number: 6933383
    Abstract: An efficient method for the synthesis of aminosterol compounds such as squalamine and compound 1436 is described. A method of the invention provides for regioselective oxidation and regioselective sulfonation of a fused ring system. The fused ring base can be, for example, a steroid ring base. The aminosterol compounds are effective as, for example, antibiotics, antiangiogenic agents and NHE3 inhibitors.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: August 23, 2005
    Assignee: Genaera Corporation
    Inventors: William A. Kinney, Xuehai Zhang, Ronald Michalak
  • Patent number: 5973172
    Abstract: The invention describes 14,17-C.sub.2 -bridged steroids of general formula (I), ##STR1## wherein the various R groups are as defined in the specification, and wherein said steroids are in contrast, with the disclaimed compound, the new compounds are available even after peroral administration with high gestagenic action and are suitable for the production of pharmaceutical agents.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: October 26, 1999
    Assignee: Schering Akitengesellschaft
    Inventors: Klaus Schollkopf, Wolfgang Halfbrodt, Joachim Kuhnke, Wolfgang Schwede, Karl-Heinrich Fritzemeier, Rolf Krattenmacher, Hans-Peter Muhn
  • Patent number: 5731447
    Abstract: A process for the preparation of a compound of the formula ##STR1##
    Type: Grant
    Filed: June 10, 1996
    Date of Patent: March 24, 1998
    Assignee: Roussel Uclaf
    Inventors: Jean Buendia, Patrick Roussel, Michel Vivat
  • Patent number: 5128464
    Abstract: 6,6-Ethylenedioxy-22R-hydroxy-2R,3S-isopropylidenedioxy-5.alpha.-cholest-23 -yne, useful as an intermediate for the synthesis of brassinolide.
    Type: Grant
    Filed: May 21, 1990
    Date of Patent: July 7, 1992
    Assignee: Fuji Yakuhin Kogyo Kabushiki Kaisha
    Inventors: Masakazu Aburatani, Tadashi Takeuchi, Kenji Mori
  • Patent number: 4939247
    Abstract: Gamma-lactone derivatives represented by the formula (I) ##STR1## wherein when R.sup.1 is methyl group, R.sup.2 is hydrogen, hydroxyl group or trifluoroacetoxyl group and R.sup.2 may combine with R.sup.3 to form a pi bond; when R.sup.1 combines with R.sup.2 to form methylene group, R.sup.3 is hydrogen; R.sup.4 and R.sup.6 are hydrogen, respectively, or may combine to form a pi bond; R.sup.5 is hydrogen or a protecting group for hydroxyl group; R.sup.7 is hydrogen or straight-chain or branched alkyl group; and St is a steroid nucleus represented by the following formula (B): ##STR2## According to the process of the present invention, the introduction of carbon chains which form polyhydroxylated steroid side chains of brassinolides or the like into steroid nucleus is carried out in one-step with the control of stereochemistry of the contiguous four acyclic chiral centers.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: July 3, 1990
    Assignee: Itaro Horiuchi & Co., Ltd.
    Inventors: Tetsuji Kametani, Toshio Honda
  • Patent number: 4874551
    Abstract: Novel .delta.-lactone derivatives which are useful as intermediate for a synthesis of brassinolide, epibrassinolide or bisnorbrassinolide and a process of preparing them are disclosed.According to the process of the present invention, the introduction of carbon chains which form polyhydroxylated steroid side chains of brassinolides or the like into steroid nucleus is carried out in one-step with the control of stereochemistry of the contiguous four acyclic chiral centers.
    Type: Grant
    Filed: April 6, 1987
    Date of Patent: October 17, 1989
    Assignee: Itaro Horiuchi & Co., Ltd
    Inventors: Tetsuji Kametani, Toshio Honda